Lake Street Initiates Buy Rating for Treace Medical
Lake Street starts coverage on Treace Medical (TMCI) with a Buy rating and $14.50 price target. Anticipates significant portfolio growth by 2025.
Lake Street initiated coverage of Treace Medical (TMCI) with a Buy rating and $14.50 price target, expecting major portfolio additions in 2025.